A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors (Q42454105)
Jump to navigation
Jump to search
scientific article published on 12 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors |
scientific article published on 12 February 2014 |
Statements
1 reference
A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors (English)
1 reference
Jose Baselga
1 reference
Reinhard Dummer
1 reference
Jordi Rodon
1 reference
Hussein A Tawbi
1 reference
Anne L Thomas
1 reference
Ronald G Stoller
1 reference
Christian P Turtschi
1 reference
John Sarantopoulos
1 reference
Devalingam Mahalingam
1 reference
Yaping Shou
1 reference
Melissa A Moles
1 reference
Lin Yang
1 reference
Camille Granvil
1 reference
Eunju Hurh
1 reference
Kristine L Rose
1 reference
Dereck D Amakye
1 reference
Alain C Mita
1 reference
12 February 2014
1 reference
1 reference
20
1 reference
7
1 reference
1900-1909
1 reference
Identifiers
1 reference
1 reference